Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Scientists Devise Innovative Method to Profile and Predict the Behavior of Proteins

Published: Friday, August 09, 2013
Last Updated: Friday, August 09, 2013
Bookmark and Share
A class of proteins that are made up of multiple, interlocking molecular components, enzymes perform a variety of tasks inside each cell.

However, precisely how these components work together to complete these tasks has long eluded scientists.

But now, a team of researchers has found a way to map an enzyme’s underlying molecular machinery, revealing patterns that could allow them to predict how an enzyme behaves – and what happens when this process disrupted.

In the latest issue of the journal Cell, a team of scientists led by Gladstone Institutes and UC San Francisco investigator Nevan Krogan, PhD, Texas A&M University’s Craig Kaplan, PhD, and UCSF professor Christine Guthrie, PhD, describe a new technique – called the point mutant E-MAP (pE-MAP) approach—that gives researchers the ability to pinpoint and map thousands of interactions between each of an enzyme’s many moving parts.

The researchers focused on a well-known enzyme – called RNA polymerase II (RNAPII) – and used the single-cellular yeast species S. cerevisiae as a model. Researchers had previously mapped the physical structure of RNAPII, but not how various parts of the enzyme work with other proteins within the cell to perform vital functions.

“Scientists know RNAPII’s physical structure, but this large enzyme has many distinct regions that each perform distinct functions,” said Kaplan, who is also a scientist at Texas A&M AgriLife. “We wanted to connect the dots between these regions and their function.”

In laboratory experiments, the team took a genetic approach – generating 53 variations of RNAPII, so-called RNAPII “mutants,” that each changed a specific part of RNAPII. They wanted to test each mutant against a particular function. In this way, they could link a specific region in the enzyme to a specific function.

But to do so, they had to compare each of the mutants against thousands of functions that RNAPII might be involved in within the cell – an immense task that couldn’t be accomplished by traditional methods. So the team developed the pE-MAP approach.

“Instead of crossing a single point mutant with one or two different mutants, pE-MAP lets us cross each one with more than 1,000,” said Krogan, who also directs the California Institute for Quantitative Biosciences, or QB3, at UCSF. “This gives us 1,000 data points for each mutant, which we then use to build our high-resolution profiles.”

“Until now, the only way to get similar information was to deactivate, or “knock out” specific genes within an enzyme and observe the impact,” explained Hannes Braberg, a graduate student in Krogan’s lab and the paper’s lead author. “But RNAPII is so critical that deactivating even one gene often kills the cell. So instead of knocking out the genes, we mutated them.”

The team then correlated the newly generated profiles to how well each variation of RNAPII could transcribe DNA into RNA – the enzyme’s most important function. The research team found that some of the RNAPII mutants transcribed more slowly than the others, while others were much faster. Further analysis revealed that the slow transcribers showed key similarities with each other, as did the fast transcribers. A pattern began to emerge that allowed them to predict the transcription speed – fast or slow – for each mutant.

And then the team discovered yet another phenomena related to transcription, involving a process called splicing, whereby specific stretches of non-coding RNA are cut out, and what remains is stitched back together. Previously, scientists had hypothesized that the transcription speed was related to splicing – in that fast transcribers would be less accurate splicers, and vice versa. But no one had been able to see it in action. So Guthrie, whose lab researches splicing, used the profiles generated from the pE-MAP approach to observe in real time how different transcription speeds affected splicing precision.

“When you slow down transcription, splicing gets more efficient,” said Guthrie. “We saw the opposite effect in our fast transcribers—which had long been predicted but had never before been observed. This was another testament to the power of the pE-MAP approach.”

The approach used here could be applied to studies of other enzymes, explained the authors. And what the researchers learn could then be used to develop an understanding of how mutations in enzymes like RNAPII lead to specific disease states – and may ultimately inform our ability to correct them.

This research received support from QB3, the National Institutes of Health, the National Science Foundation, the Searles Scholars Program and the W.M. Keck Foundation.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,100+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Study Yields the Key to Effective Personalized Medicine
A team of UCLA bioengineers and surgeons has taken a major step toward making personalized medicine a reality.
Monday, April 11, 2016
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Monday, February 08, 2016
Science Magazine Names CRISPR ‘Breakthrough of the Year’
In its year-end issue, the journal Science chose the CRISPR genome-editing technology invented at UC Berkeley 2015’s Breakthrough of the Year.
Monday, December 21, 2015
New Method for Screening Cancer Cells
Parallel microfiltration could lead to better treatments for a number of diseases, UCLA-led study says.
Thursday, December 03, 2015
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
Monday, November 23, 2015
Double Enzyme Hit May Explain Common Cancer Drug Side Effect
Mouse study suggests genomic screening before treatment may help prevent anemia.
Wednesday, October 14, 2015
Opening the Door to Safer, More Precise Cancer Therapies
New method regulates when, and how strongly, cancer-killing therapeutic T cells are activated.
Tuesday, September 29, 2015
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Delivering Drugs to the Right Place
Thomas Weimbs has developed a targeted drug delivery method that could potentially slow the progression of polycystic kidney disease.
Monday, June 29, 2015
Designing New Pain Relief Drugs
Researchers have identified the molecular interactions that allow capsaicin to activate the body’s primary receptor for sensing heat and pain, paving the way for the design of more selective and effective drugs to relieve pain.
Thursday, June 11, 2015
Genetic Markers for Detecting and Treating Ovarian Cancer
Custom bioinformatics algorithm identifies human mRNAs that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Wednesday, May 27, 2015
Using microRNA Fit to a T (Cell)
Researchers show B cells can deliver potentially therapeutic bits of modified RNA.
Friday, November 29, 2013
Digging Deeper Into Cancer
What a pathologist looks for in a Pap test sample, but hopes not to find, are oddly shaped cells with abnormally large nuclei. The same is true for prostate and lung cancer biopsies.
Tuesday, November 19, 2013
Nanotech Method Show Promise Against Pancreatic Cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer.
Monday, November 18, 2013
Researchers Un-Junking Junk DNA
A study shines a new light on molecular tools our cells use to govern regulated gene expression.
Wednesday, November 13, 2013
Scientific News
Integrated Omics Analysis
Studying multi-omics promises to give a more holistic picture of the organism and its place in its ecosystem, however despite the complexities involved those within the field are optimistic.
Unravelling the Role of Key Genes and DNA Methylation in Blood Cell Malignancies
Researchers from the University of Nebraska Medical Center have demonstrated the role of Dnmt3a in safeguarding normal haematopoiesis.
Agilent Presents Early Career Professor Award to Dr. Roeland Verhaak
JAX professor recognized for the development and implementation of workflows for the analysis of big-data from transcriptomics to next generation sequencing approaches.
New Mechanism of Plant RNA Degradation Identified
Researchers have identified a novel mechanism by which RNA is degraded.
Enlisting Insects to Protect Agriculture
New program aims for insect delivery of protective genes to modify mature plants within a single growing season.
Ovarian Cancer Insight
Study showed tumours release cytokines to attract macrophages, which secrete growth factors that in turn promote tumour growth.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Questioning the Safety of Selenium to Combat Cancer
Research indicates the need for change in practice as selenium supplements cannot be recommended for preventing colorectal cancer.
Supercomputers Could Improve Cancer Diagnostics
Researchers push the boundaries of cancer research through high-performance computing to map the human immunone.
Transgenomic, Precipio Diagnostics Merger
Merger will creates a robust diagnostic platform focused on improving accuracy of cancer diagnoses.

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos